Junshi Biosciences Announces the Acceptance of the sNDA for Toripalimab as the 1st-line Treatment of HER2-expressing Urothelial Carcinoma
Notified -
Globe Newswire8-08-2025, 19:00
MULTIMEDIA UPDATE -- Game, Set, Match: JOE & THE JUICE Welcomes Novak Djokovic to the Family 4-06-2025, 21:07